What is intelligencia.ai?
Intelligencia AI is an AI‑driven platform that supports pharmaceutical, biotech and research organizations in de‑risking and optimizing clinical development. It delivers accurate probability‑of‑success (PTRS) assessments for drug candidates across therapeutic areas, validated retrospectively and prospectively with high prospective accuracy.
The solution aggregates real‑time clinical trial data through proprietary ontologies, providing a single source of harmonized information for consistent risk evaluation. Explainable AI models reveal the features and drivers behind each risk score, enabling transparent decision‑making.
Users can benchmark their pipeline against the competitive landscape, identify acquisition or licensing opportunities, and design clinical trials that reduce regulatory and technical risk. The platform standardizes portfolio risk evaluation, supports portfolio‑level strategy, and continuously incorporates user feedback to refine predictive models.
intelligencia.ai user reviews
Based on 1 review, 100.0% of users recommend intelligencia.ai, rated highly for quality results.
Liked for
Would you recommend intelligencia.ai?
intelligencia.ai's key features
-
AI-driven drug success assessment
-
Real-time clinical program tracking
-
Ontology-based data organization
-
Explainable AI with transparent drivers
-
Prospective accuracy over 80%
-
Single source harmonized data
-
Portfolio risk standardization across portfolios
intelligencia.ai use cases
-
Generate real‑time risk scores for ongoing Phase II trials, flagging regulatory hotspots and suggesting mitigation actions within minutes of data influx, enabling sponsors to pivot before costly delays
-
Benchmark candidate pipelines against industry success probabilities, automatically scoring each compound with explainable factors so portfolio managers can prioritize high‑impact acquisitions and divest underperformers
-
Simulate trial design variations, feeding alternative enrollment and dosage parameters into the AI to forecast probability‑of‑success curves, allowing clinical teams to select the most efficient protocol that balances patient safety and regulatory compliance
Who is it for?
-
Data analysts
-
Trial designers
-
Project managers
-
Executive leaders
-
Regulatory affairs
